ETF Buy Idea: Target Exceeded at $42. Take Profit

+30 Take Profit Opportunities: Our Capabilities > https://www.unum.capital/post/capabilities

Free Content: July 2026 > https://www.unum.capital/post/rjuly2026

Trade Local & Global Financial Markets with Unum Capital.

To get started, email tradingdesk@unum.co.za

NOTE: When Published Intraday (JSE Equities), Prices Are Delayed By 15 Minutes

ARK Genomic Revolution ETF (ARKG). Hot theme in the last few weeks. We called it in October at much lower levels.

---

Previous Post (03 October 2025): Buy Idea: ARK Genomic Revolution ETF

Technical recovery in a lagging industry/sector.

The ARK Genomic Revolution ETF (ARKG) is an actively managed fund from ARK Invest that invests in companies involved in the "genomics revolution," such as those in healthcare, information technology, and materials that benefit from technological advances in genomics and related fields. It seeks long-term growth and focuses on companies poised to profit from advances in genomics and life-enhancement technologies.

Buy at current level $29.81 (or better)

Stop-loss: $25.50

Target: $42.00

Lester Davids

Senior Investment Analyst: Unum Capital